Teleflex Incorporated (NYSE:TFX) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Teleflex Incorporated (NYSE:TFXGet Free Report) have earned a consensus recommendation of “Moderate Buy” from the eight ratings firms that are presently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $265.57.

Several equities research analysts have recently weighed in on TFX shares. Stephens increased their price target on Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a report on Friday, August 2nd. Truist Financial increased their target price on Teleflex from $240.00 to $247.00 and gave the stock a “hold” rating in a research note on Monday, August 5th. Royal Bank of Canada boosted their target price on shares of Teleflex from $235.00 to $260.00 and gave the company an “outperform” rating in a research note on Friday, August 2nd. Finally, Piper Sandler upgraded shares of Teleflex from a “neutral” rating to an “overweight” rating and upped their price target for the stock from $205.00 to $245.00 in a report on Monday, July 1st.

View Our Latest Stock Analysis on TFX

Insider Buying and Selling

In other Teleflex news, Director Stuart A. Randle sold 2,674 shares of the stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $238.93, for a total transaction of $638,898.82. Following the transaction, the director now directly owns 5,496 shares in the company, valued at approximately $1,313,159.28. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.43% of the stock is owned by insiders.

Hedge Funds Weigh In On Teleflex

Hedge funds and other institutional investors have recently modified their holdings of the business. International Assets Investment Management LLC boosted its position in Teleflex by 20,300.0% during the 4th quarter. International Assets Investment Management LLC now owns 2,244 shares of the medical technology company’s stock valued at $560,000 after acquiring an additional 2,233 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in Teleflex by 8.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 356,532 shares of the medical technology company’s stock valued at $88,900,000 after purchasing an additional 27,048 shares during the last quarter. Envestnet Portfolio Solutions Inc. raised its holdings in Teleflex by 5.6% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 1,489 shares of the medical technology company’s stock worth $371,000 after purchasing an additional 79 shares in the last quarter. Boston Partners purchased a new stake in shares of Teleflex during the fourth quarter valued at about $343,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in shares of Teleflex by 9.0% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 46,258 shares of the medical technology company’s stock valued at $11,195,000 after buying an additional 3,828 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors.

Teleflex Trading Down 1.3 %

TFX stock opened at $242.50 on Monday. Teleflex has a twelve month low of $177.63 and a twelve month high of $257.85. The stock has a market capitalization of $11.42 billion, a price-to-earnings ratio of 38.92, a price-to-earnings-growth ratio of 2.23 and a beta of 1.16. The company has a quick ratio of 1.44, a current ratio of 2.58 and a debt-to-equity ratio of 0.36. The firm’s fifty day simple moving average is $235.35 and its two-hundred day simple moving average is $220.48.

Teleflex (NYSE:TFXGet Free Report) last released its quarterly earnings results on Thursday, August 1st. The medical technology company reported $3.42 EPS for the quarter, topping analysts’ consensus estimates of $3.33 by $0.09. The firm had revenue of $749.70 million during the quarter, compared to analysts’ expectations of $762.98 million. Teleflex had a net margin of 8.76% and a return on equity of 14.51%. The firm’s revenue for the quarter was up .9% compared to the same quarter last year. During the same period in the previous year, the company earned $3.41 EPS. As a group, analysts anticipate that Teleflex will post 13.97 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, September 16th. Stockholders of record on Thursday, August 15th were paid a dividend of $0.34 per share. The ex-dividend date was Thursday, August 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.56%. Teleflex’s dividend payout ratio is currently 21.83%.

Teleflex Company Profile

(Get Free Report

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Read More

Analyst Recommendations for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.